Substance / Medication

Pantothenic acid

Overview

Active Ingredient
niacinamide
RxNorm CUI
7405

Indications

Dialyvite 3000 is a prescription folic acid supplement with additional nutrients indicated for use in improving the nutritional status of renal dialysis patients.

Labeler: Hillestad Pharmaceuticals USAUpdated: 2027-01-27T00:00:00.000ZFull label on DailyMed

Contraindications

When this intervention should not be used

This product is contraindicated in patients with known hypersensitivity to any of the ingredients.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Detailed dosage and administration information is available in the full FDA drug label.

View full prescribing information on DailyMed

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

20 trials linked to this intervention

20
Total Trials
0
Recruiting
10
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Pellagra may be a rare secondary complication of anorexia nervosa: a systematic review of the literature.
Prousky Jonathan E · Altern Med Rev · 2003
PMID: 12777163Meta-Analysis
Acute pantothenic acid and cysteine supplementation does not affect muscle coenzyme A content, fuel selection, or exercise performance in healthy humans.
Wall Benjamin T, Stephens Francis B, Marimuthu Kanagaraj et al. · J Appl Physiol (1985) · 2012
PMID: 22052867RCT
Pellagra a review exploring causes and mechanisms, including isoniazid-induced pellagra.
Prabhu Dhanashree, Dawe Robert S, Mponda Kelvin · Photodermatol Photoimmunol Photomed · 2021
PMID: 33471377Review
[Cutaneous manifestations of nutritional deficiencies].
Schlomer Tatiana, Di Lucca Julie, Bart Pierre-Alexandre · Rev Med Suisse · 2019
PMID: 31746568Review
Drug-induced photosensitivity: new insights into pathomechanisms and clinical variation through basic and applied science.
Khandpur S, Porter R M, Boulton S J et al. · Br J Dermatol · 2017
PMID: 27510322Review
[Niacin deficiency and cutaneous immunity].
Ikenouchi-Sugita Atsuko, Sugita Kazunari · Nihon Rinsho Meneki Gakkai Kaishi · 2015
PMID: 25765687Review
Pellagra's Three Ds: Dermatology, Death, and Dracula.
Barsell Alexandra, Norton Scott A · JAMA Dermatol · 2015
PMID: 26352123Review

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Adverse reaction and safety data for this drug is sourced from the FDA-approved label.

View adverse reactions & drug interactions on DailyMed

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Pantothenic acid (substance)
SNOMED CT
86431009
UMLS CUI
C0028027
RxNorm CUI
7405
Labeler
Hillestad Pharmaceuticals USA

Clinical Data

This intervention maps to 12 entities in the Ltrl knowledge graph.

7
Conditions
2
Biomarkers
2
Specialists
0
Symptoms
20
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.